Merck & Co. logo
Merck & Co. MRK
€ 94.28 0.0%

Geschäftsbericht 2025
hinzugefügt 24.02.2026

report update icon

Merck & Co. DSO 2011-2026 | MRK

DSO Jährlich Merck & Co.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
61.9 58.7 60.1 57.5 64 64.3 52.8 61 62.5 64.3 59.9 57.3 59.5 59.2 62.8

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
64.3 52.8 60.4

DSO Vierteljährlich Merck & Co.

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
63.3 65.3 65.1 63.1 65.2 62.9 61.2 65.1 62.6 - 28.9 30.7 54.7 - 56.9 64.3 64.6 - 56.8 71.5 55.4 - 49.9 52.6 58.4 - 59.8 61.7 63.4 - 60.7 63.2 -48.8 K - 30.5 K 160 K 18.1 K - 9.39 K 296 K 4.13 K - 25.2 K 6.57 K 5.08 K - 6.43 K 5.65 K 5.1 K - 4.43 K 4.93 K 6.61 K - 4.68 K 13.5 K -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
296 K -48.8 K 12.7 K

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 21.65 - $ 1.01 B usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 0.9 -0.18 % $ 6.62 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
37.5 $ 22.3 - $ 3.7 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
87.4 - - $ 35.4 M usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
148 $ 6.85 - $ 196 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
24.7 - -0.88 % $ 598 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
198 $ 1.19 - $ 198 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.1 - $ 438 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 23.42 - $ 2.98 B usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
47.5 $ 8.25 - $ 74.5 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.42 - $ 378 M britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 2.92 - $ 4.81 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Kamada Ltd. Kamada Ltd.
KMDA
103 $ 8.2 - $ 260 M israelIsrael